4D Duke Microscope Integrated Optical Coherence Tomography in a Zeiss Artevo 800
Launched by DUKE UNIVERSITY · Jun 9, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is testing a new imaging tool called 4D Microscope Integrated Optical Coherence Tomography (or 4D MIOCT) during eye surgeries. This technology helps doctors see detailed, real-time pictures of the eye’s structures while they operate, which could improve how certain eye diseases are treated. The study will check how easy and safe the tool is to use and how well it shows important parts of the eye during different types of eye surgeries.
Adults 18 years and older who are having surgery for an eye disease and can give informed consent may be eligible to join. However, people with eye conditions that make it hard to use this imaging tool won’t be able to participate. If you take part, the new imaging system will be used during your surgery to help the surgeons see inside your eye more clearly. This is one of the first times this technology is being tested in people, so the study team will carefully watch how it works and if it’s safe to use.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult participants 18 years of age and older
- • Patients undergoing surgery for ocular disease
- • Adults able and willing to give informed consent to participate in the study
- Exclusion Criteria:
- • Patients with any ocular disease that restricts the ability to perform OCT scanning
About Duke University
Duke University, a leading academic and research institution located in Durham, North Carolina, is renowned for its commitment to advancing healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, Duke conducts a wide array of clinical trials aimed at developing cutting-edge therapies and improving patient outcomes across various medical fields. The university's Clinical Research Institute provides comprehensive support for trial design, implementation, and regulatory compliance, ensuring that all research adheres to the highest ethical and scientific standards. Duke’s dedication to translating research findings into effective clinical practices underscores its role as a pivotal contributor to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Durham, North Carolina, United States
Patients applied
Trial Officials
Cynthia A Toth, MD
Principal Investigator
Duke University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported